Special Issue "Pediatric Oncology and Chemotherapy: Challenges and Strategies"
A special issue of Pediatric Reports (ISSN 2036-7503).
Deadline for manuscript submissions: closed (18 July 2023) | Viewed by 3624
Cancer is one of the leading causes of death among both adults and children. In the United States, pediatric oncology gradually developed in the years following the 1950s. To date, chemotherapy is still one of the major therapeutic strategies in cancer treatment. Chemotherapy often causes serious side effects, which potentially contribute to morbidity and affect patients’ life quality. Such side effects could cause more serious subsequences in children. Compared to adult cancer, pediatric cancer is rare in absolute numbers. However, survivors of pediatric cancer often suffer from side effects and long-term health complications when they reach old age.
A set of problems have been highlighted due to the difference between pediatric and adult cancers. Furthermore, the number of approved anticancer therapies for pediatric cancer is significantly smaller than for adults due to specific requirements for a therapy to treat pediatric patients. All these in turn make optimizing therapeutic intervention at children rather difficult. This Special Issue aims at highlighting studies and reviews regarding pediatric oncology and chemotherapy. The scope of this Special Issue includes but is not limited to pediatric oncology, chemotherapeutic strategies, personalized medicine, and target therapy.
Thanks for your collaboration.
Dr. Jingquan Wang
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pediatric Reports is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- pediatric cancer
- side effects
- cancer treatment